awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47099597-041BF3C7-557C-4009-89FB-5C5F94D926E9
Q47099597-041BF3C7-557C-4009-89FB-5C5F94D926E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47099597-041BF3C7-557C-4009-89FB-5C5F94D926E9
Improving Access to Cancer Treatments: The Role of Biosimilars.
P2860
Q47099597-041BF3C7-557C-4009-89FB-5C5F94D926E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47099597-041BF3C7-557C-4009-89FB-5C5F94D926E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97c1a1219e865672471ea75e4420041935a2645e
P2860
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety